{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:12Z","timestamp":1794047472826,"version":"4.8.0"},"reference-count":50,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"11","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>T-cell acute lymphoblastic leukemia (T-ALL) is a cancer of the immune system. Approximately 20% of pediatric and 50% of adult T-ALL patients have refractory disease or relapse and die from the disease. To improve patient outcome new therapeutics are needed. With the aim to identify new therapeutic targets, we combined the analysis of T-ALL gene expression and metabolism to identify the metabolic adaptations that T-ALL cells exhibit. We found that glutamine uptake is essential for T-ALL proliferation. Isotope tracing experiments showed that glutamine fuels aspartate synthesis through the tricarboxylic acid cycle and that glutamine and glutamine-derived aspartate together supply three nitrogen atoms in purines and all but one atom in pyrimidine rings. We show that the glutamate-aspartate transporter EAAT1 (SLC1A3), which is normally expressed in the central nervous system, is crucial for glutamine conversion to aspartate and nucleotides and that T-ALL cell proliferation depends on EAAT1 function. Through this work, we identify EAAT1 as a novel therapeutic target for T-ALL treatment.<\/jats:p>","DOI":"10.3324\/haematol.2023.283471","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T08:25:23Z","timestamp":1717057523000},"page":"3505-3519","source":"Crossref","is-referenced-by-count":5,"title":["The glutamate\/aspartate transporter EAAT1 is crucial for T-cell acute lymphoblastic leukemia proliferation and survival"],"prefix":"10.3324","volume":"109","author":[{"given":"Vesna S.","family":"Stanulovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shorog","family":"Al Omair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.C.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Potluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Fulton-Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Gudgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Roels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey A.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sovan","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Taghon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dimeloe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich L.","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Hoogenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"68058","doi-asserted-by":"crossref","unstructured":"Homminga I, Pieters R, Langerak AW. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell. 2011; 19(4):484-497.","DOI":"10.1016\/j.ccr.2011.02.008"},{"key":"68059","doi-asserted-by":"crossref","unstructured":"Liu Y, Easton J, Shao Y. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017; 49(8):1211-1218.","DOI":"10.1038\/ng.3909"},{"key":"68060","doi-asserted-by":"crossref","unstructured":"Chessells JM, Veys P, Kempski H. Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia. Br J Haematol. 2003; 123(3):396-405.","DOI":"10.1046\/j.1365-2141.2003.04584.x"},{"key":"68061","doi-asserted-by":"crossref","unstructured":"Vora A, Wade R, Mitchell CD, Goulden N, Richards S. Improved outcome for children and young adults with T-cell acute lymphoblastic leukaemia (ALL): results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003. Blood. 2008; 112(11):908.","DOI":"10.1182\/blood.V112.11.908.908"},{"key":"68062","doi-asserted-by":"crossref","unstructured":"Hastings C, Gaynon PS, Nachman JB. Increased post-induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (&gt;\/=200 x 10(9) \/l) with T cell acute lymphoblastic leukaemia but not B cell disease: a report from the Children\u2019s Oncology Group. Br J Haematol. 2015; 168(4):533-546.","DOI":"10.1111\/bjh.13160"},{"key":"68063","doi-asserted-by":"crossref","unstructured":"Vora A, Goulden N, Mitchell C. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standardrisk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2014; 15(8):809-818.","DOI":"10.1016\/S1470-2045(14)70243-8"},{"key":"68064","doi-asserted-by":"crossref","unstructured":"Nagarajan A, Malvi P, Wajapeyee N. Oncogene-directed alterations in cancer cell metabolism. Trends Cancer. 2016; 2(7):365-377.","DOI":"10.1016\/j.trecan.2016.06.002"},{"key":"68065","doi-asserted-by":"crossref","unstructured":"Shoshan M. On mitochondrial metabolism in tumor biology. Curr Opin Oncol. 2017; 29(1):48-54.","DOI":"10.1097\/CCO.0000000000000336"},{"key":"68066","doi-asserted-by":"crossref","unstructured":"Tennant DA, Duran RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer. 2010; 10(4):267-277.","DOI":"10.1038\/nrc2817"},{"key":"68067","doi-asserted-by":"crossref","unstructured":"Mossmann D, Park S, Hall MN. mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat Rev Cancer. 2018; 18(12):744-757.","DOI":"10.1038\/s41568-018-0074-8"},{"key":"68068","doi-asserted-by":"crossref","unstructured":"Fruman DA, Rommel C. PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov. 2014; 13(2):140-156.","DOI":"10.1038\/nrd4204"},{"key":"68069","doi-asserted-by":"crossref","unstructured":"Mayer IA, Arteaga CL. The PI3K\/AKT pathway as a target for cancer treatment. Annu Rev Med. 2016; 67:11-28.","DOI":"10.1146\/annurev-med-062913-051343"},{"key":"68070","doi-asserted-by":"crossref","unstructured":"Raivio KO, Andersson LC. Glutamine requirements for purine metabolism in leukemic lymphoblasts. Leuk Res. 1982; 6(1):111-115.","DOI":"10.1016\/0145-2126(82)90049-2"},{"key":"68071","doi-asserted-by":"crossref","unstructured":"Kitoh T, Kubota M, Takimoto T. Metabolic basis for differential glutamine requirements of human leukemia cell lines. J Cell Physiol. 1990; 143(1):150-153.","DOI":"10.1002\/jcp.1041430120"},{"key":"68072","doi-asserted-by":"crossref","unstructured":"Hu J, Wang T, Xu J. WEE1 inhibition induces glutamine addiction in T-cell acute lymphoblastic leukemia. Haematologica. 2021; 106(7):1816-1827.","DOI":"10.3324\/haematol.2019.231126"},{"key":"68073","doi-asserted-by":"crossref","unstructured":"Herranz D, Ambesi-Impiombato A, Sudderth J. Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia. Nat Med. 2015; 21(10):1182-1189.","DOI":"10.1038\/nm.3955"},{"key":"68074","doi-asserted-by":"crossref","unstructured":"Nguyen TL, Nokin MJ, Teres S. Downregulation of glutamine synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia. Mol Oncol. 2021; 15(5):1412-1431.","DOI":"10.1002\/1878-0261.12877"},{"key":"68075","doi-asserted-by":"crossref","unstructured":"Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J Neurosci. 1995; 15(3 Pt 1):1835-1853.","DOI":"10.1523\/JNEUROSCI.15-03-01835.1995"},{"key":"68076","doi-asserted-by":"crossref","unstructured":"Storck T, Schulte S, Hofmann K, Stoffel W. Structure, expression, and functional analysis of a Na(+)-dependent glutamate\/aspartate transporter from rat brain. Proc Natl Acad Sci U S A. 1992; 89(22):10955-10959.","DOI":"10.1073\/pnas.89.22.10955"},{"key":"68077","doi-asserted-by":"crossref","unstructured":"Stanulovic VS, Cauchy P, Assi SA, Hoogenkamp M. LMO2 is required for TAL1 DNA binding activity and initiation of definitive haematopoiesis at the haemangioblast stage. Nucleic Acids Res. 2017; 45(17):9874-9888.","DOI":"10.1093\/nar\/gkx573"},{"key":"68078","doi-asserted-by":"crossref","unstructured":"Pear WS, Miller JP, Xu L. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow. Blood. 1998; 92(10):3780-3792.","DOI":"10.1182\/blood.V92.10.3780.422k15_3780_3792"},{"key":"68079","doi-asserted-by":"crossref","unstructured":"Dow LE, Premsrirut PK, Zuber J. A pipeline for the generation of shRNA transgenic mice. Nat Protoc. 2012; 7(2):374-393.","DOI":"10.1038\/nprot.2011.446"},{"key":"68080","doi-asserted-by":"crossref","unstructured":"Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000; 7(12):1063-1066.","DOI":"10.1038\/sj.gt.3301206"},{"key":"68081","doi-asserted-by":"crossref","unstructured":"Paddison PJ, Cleary M, Silva JM. Cloning of short hairpin RNAs for gene knockdown in mammalian cells. Nat Methods. 2004; 1(2):163-167.","DOI":"10.1038\/nmeth1104-163"},{"key":"68082","doi-asserted-by":"crossref","unstructured":"Glover JD, Taylor L, Sherman A, Zeiger-Poli C, Sang HM, McGrew MJ. A novel piggyBac transposon inducible expression system identifies a role for AKT signalling in primordial germ cell migration. PLoS One. 2013; 8(11):e77222.","DOI":"10.1371\/journal.pone.0077222"},{"key":"68083","doi-asserted-by":"crossref","unstructured":"Wang W, Lin C, Lu D. Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc Natl Acad Sci U S A. 2008; 105(27):9290-9295.","DOI":"10.1073\/pnas.0801017105"},{"key":"68084","doi-asserted-by":"crossref","unstructured":"Ludwig C, Gunther UL. MetaboLab--advanced NMR data processing and analysis for metabolomics. BMC Bioinformatics. 2011; 12:366.","DOI":"10.1186\/1471-2105-12-366"},{"key":"68085","doi-asserted-by":"crossref","unstructured":"Sandberg Y, Verhaaf B, van Gastel-Mol EJ. Human T-cell lines with well-defined T-cell receptor gene rearrangements as controls for the BIOMED-2 multiplex polymerase chain reaction tubes. Leukemia. 2007; 21(2):230-237.","DOI":"10.1038\/sj.leu.2404486"},{"key":"68086","doi-asserted-by":"crossref","unstructured":"Etchin J, Sanda T, Mansour MR. KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia. Br J Haematol. 2013; 161(1):117-127.","DOI":"10.1111\/bjh.12231"},{"key":"68087","doi-asserted-by":"crossref","unstructured":"Roth E, Ollenschlager G, Hamilton G. Influence of two glutamine-containing dipeptides on growth of mammalian cells. In Vitro Cell Dev Biol. 1988; 24(7):696-698.","DOI":"10.1007\/BF02623607"},{"key":"68088","doi-asserted-by":"crossref","unstructured":"Christie A, Butler M. Glutamine-based dipeptides are utilized in mammalian cell culture by extracellular hydrolysis catalyzed by a specific peptidase. J Biotechnol. 1994; 37(3):277-290.","DOI":"10.1016\/0168-1656(94)90134-1"},{"key":"68089","doi-asserted-by":"crossref","unstructured":"Ralphe JC, Segar JL, Schutte BC, Scholz TD. Localization and function of the brain excitatory amino acid transporter type 1 in cardiac mitochondria. J Mol Cell Cardiol. 2004; 37(1):33-41.","DOI":"10.1016\/j.yjmcc.2004.04.008"},{"key":"68090","doi-asserted-by":"crossref","unstructured":"Lasorsa FM, Pinton P, Palmieri L, Fiermonte G, Rizzuto R, Palmieri F. Recombinant expression of the Ca(2+)-sensitive aspartate\/glutamate carrier increases mitochondrial ATP production in agonist-stimulated Chinese hamster ovary cells. J Biol Chem. 2003; 278(40):38686-38692.","DOI":"10.1074\/jbc.M304988200"},{"key":"68091","doi-asserted-by":"crossref","unstructured":"Fagerberg L, Hallstrom BM, Oksvold P. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014; 13(2):397-406.","DOI":"10.1074\/mcp.M113.035600"},{"key":"68092","doi-asserted-by":"crossref","unstructured":"Ptasinska A, Assi SA, Martinez-Soria N. Identification of a dynamic core transcriptional network in t(8;21) AML that regulates differentiation block and self-renewal. Cell Rep. 2014; 8(6):1974-1988.","DOI":"10.1016\/j.celrep.2014.08.024"},{"key":"68093","doi-asserted-by":"crossref","unstructured":"Roels J, Kuchmiy A, De Decker M. Distinct and temporary-restricted epigenetic mechanisms regulate human alphabeta and gammadelta T cell development. Nat Immunol. 2020; 21(10):1280-1292.","DOI":"10.1038\/s41590-020-0747-9"},{"key":"68094","doi-asserted-by":"crossref","unstructured":"Verboom K, Van Loocke W, Volders PJ. A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing. Haematologica. 2018; 103(12):e585-e589.","DOI":"10.3324\/haematol.2018.190587"},{"key":"68095","doi-asserted-by":"crossref","unstructured":"Erichsen MN, Huynh TH, Abrahamsen B. Structure-activity relationship study of first selective inhibitor of excitatory amino acid transporter subtype 1: 2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chrom ene-3-carbonitrile (UCPH-101). J Med Chem. 2010; 53(19):7180-7191.","DOI":"10.1021\/jm1009154"},{"key":"68096","doi-asserted-by":"crossref","unstructured":"Canul-Tec JC, Assal R, Cirri E. Structure and allosteric inhibition of excitatory amino acid transporter 1. Nature. 2017; 544(7651):446-451.","DOI":"10.1038\/nature22064"},{"key":"68097","doi-asserted-by":"crossref","unstructured":"Tsherniak A, Vazquez F, Montgomery PG. Defining a cancer dependency map. Cell. 2017; 170(3):564-576.","DOI":"10.1016\/j.cell.2017.06.010"},{"key":"68098","doi-asserted-by":"crossref","unstructured":"Sun J, Nagel R, Zaal EA. SLC1A3 contributes to L-asparaginase resistance in solid tumors. EMBO J. 2019; 38(21):e102147.","DOI":"10.15252\/embj.2019102147"},{"key":"68099","doi-asserted-by":"crossref","unstructured":"Tajan M, Hock AK, Blagih J. A role for p53 in the adaptation to glutamine starvation through the expression of SLC1A3. Cell Metab. 2018; 28(5):721-736.","DOI":"10.1016\/j.cmet.2018.07.005"},{"key":"68100","doi-asserted-by":"crossref","unstructured":"Pui CH, Campana D, Pei D. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009; 360(26):2730-2741.","DOI":"10.1056\/NEJMoa0900386"},{"key":"68101","doi-asserted-by":"crossref","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM. Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419.","DOI":"10.1126\/science.1260419"},{"key":"68102","doi-asserted-by":"crossref","unstructured":"Thangaratnarajah C, Ruprecht JJ, Kunji ER. Calcium-induced conformational changes of the regulatory domain of human mitochondrial aspartate\/glutamate carriers. Nat Commun. 2014; 5:5491.","DOI":"10.1038\/ncomms6491"},{"key":"68103","doi-asserted-by":"crossref","unstructured":"Palmieri L, Pardo B, Lasorsa FM. Citrin and aralar1 are Ca(2+)-stimulated aspartate\/glutamate transporters in mitochondria. EMBO J. 2001; 20(18):5060-5069.","DOI":"10.1093\/emboj\/20.18.5060"},{"key":"68104","doi-asserted-by":"crossref","unstructured":"LaNoue KF, Tischler ME. Electrogenic characteristics of the mitochondrial glutamate-aspartate antiporter. J Biol Chem. 1974; 249(23):7522-7528.","DOI":"10.1016\/S0021-9258(19)81269-3"},{"key":"68105","doi-asserted-by":"crossref","unstructured":"LaNoue KF, Bryla J, Bassett DJ. Energy-driven aspartate efflux from heart and liver mitochondria. J Biol Chem. 1974; 249(23):7514-7521.","DOI":"10.1016\/S0021-9258(19)81268-1"},{"key":"68106","doi-asserted-by":"crossref","unstructured":"Amoedo ND, Punzi G, Obre E. AGC1\/2, the mitochondrial aspartate-glutamate carriers. Biochim Biophys Acta. 2016; 1863(10):2394-2412.","DOI":"10.1016\/j.bbamcr.2016.04.011"},{"key":"68107","doi-asserted-by":"crossref","unstructured":"Kishton RJ, Barnes CE, Nichols AG. AMPK Is Essential to balance glycolysis and mitochondrial metabolism to control T-ALL cell stress and survival. Cell Metab. 2016; 23(4):649-662.","DOI":"10.1016\/j.cmet.2016.03.008"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283471\/77101","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283471\/77697","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11616\/77101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:06:32Z","timestamp":1794045992000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.283471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.283471","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,30]]}}}